82 related articles for article (PubMed ID: 35235021)
1. Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis.
Matsuo K; Mandelbaum R; Deshpande RR; Nusbaum DJ; Yoshihara K; Machida H; Bainvoll L; Matsuzaki S; Klar M; Roman LD; Wright JD
Arch Gynecol Obstet; 2022 Sep; 306(3):865-874. PubMed ID: 35235021
[TBL] [Abstract][Full Text] [Related]
2. Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.
Matsuo K; Mandelbaum RS; Machida H; Yoshihara K; Muggia FM; Roman LD; Wright JD
Gynecol Oncol; 2019 Jul; 154(1):169-176. PubMed ID: 31130286
[TBL] [Abstract][Full Text] [Related]
3. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
Nasioudis D; Wilson E; Mastroyannis SA; Sisti G; Haggerty AF; Ko EM; Latif NA
Anticancer Res; 2019 Sep; 39(9):4971-4975. PubMed ID: 31519603
[TBL] [Abstract][Full Text] [Related]
4. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
6. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
7. Association between uterine serous carcinoma and breast cancer.
Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
[TBL] [Abstract][Full Text] [Related]
8. Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea.
Shin DW; Choi YJ; Kim HS; Han KD; Yoon H; Park YS; Kim N; Lee DH
Dis Colon Rectum; 2018 Nov; 61(11):1250-1257. PubMed ID: 30239394
[TBL] [Abstract][Full Text] [Related]
9. Decreased breast cancer rates among women with choriocarcinoma.
Gudipudi DK; Hartzfeld K; Montemarano N; Del Priore G
Gynecol Oncol; 2008 Aug; 110(2):202-5. PubMed ID: 18514799
[TBL] [Abstract][Full Text] [Related]
10. Uterine Cancer Incidence and Mortality - United States, 1999-2016.
Henley SJ; Miller JW; Dowling NF; Benard VB; Richardson LC
MMWR Morb Mortal Wkly Rep; 2018 Dec; 67(48):1333-1338. PubMed ID: 30521505
[TBL] [Abstract][Full Text] [Related]
11. Trends in breast cancer by race and ethnicity.
Ghafoor A; Jemal A; Ward E; Cokkinides V; Smith R; Thun M
CA Cancer J Clin; 2003; 53(6):342-55. PubMed ID: 15224974
[TBL] [Abstract][Full Text] [Related]
12. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
13. [Descriptive epidemiology of gynecologic and breast cancers].
Schraub S; Alauzet E; Schaffer P; Robillard J; Menegoz F
Rev Fr Gynecol Obstet; 1992 Dec; 87(12):577-85. PubMed ID: 1485074
[TBL] [Abstract][Full Text] [Related]
14. Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers.
Tai YJ; Chiang CJ; Chiang YC; Wu CY; Lee WC; Cheng WF
Sci Rep; 2023 Jan; 13(1):1019. PubMed ID: 36658172
[TBL] [Abstract][Full Text] [Related]
15. Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Pierce SR; Stine JE; Gehrig PA; Havrilesky LJ; Secord AA; Nakayama J; Snavely AC; Moore DT; Kim KH
Gynecol Oncol; 2017 Mar; 144(3):531-535. PubMed ID: 28062116
[TBL] [Abstract][Full Text] [Related]
16. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.
Shen CC; Yang AC; Hung JH; Hu LY; Tsai SJ
Oncologist; 2015 Jan; 20(1):45-9. PubMed ID: 25410097
[TBL] [Abstract][Full Text] [Related]
17. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States).
Yu GP; Schantz SP; Neugut AI; Zhang ZF
Cancer Causes Control; 2006 May; 17(4):411-20. PubMed ID: 16596293
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
19. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
[No Abstract] [Full Text] [Related]
20. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
